InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 06/19/2019 10:30:56 AM

Wednesday, June 19, 2019 10:30:56 AM

Post# of 64
News: $ARCT Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases

Scope of the collaboration expands to include up to 12 rare disease targets and includes Arcturus nucleic acid technologies to enable mRNA, DNA, and siRNA therapeutics $30 million of upfront payments to Arcturus, including $6 million cash for collaboration agreement amendment an...

In case you are interested https://marketwirenews.com/news-releases/ultragenyx-and-arcturus-therapeutics-expand-existing-research-collaboration-and-license-agreement-to-develop-additional-nucleic-acid-therapies-for-rare-diseases-8381370.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARCT News